Nitrosonifedipine Ameliorates the Progression of Type 2 Diabetic Nephropathy by Exerting Antioxidative Effects

Diabetic nephropathy (DN) is the major cause of end-stage renal failure. Oxidative stress is implicated in the pathogenesis of DN. Nitrosonifedipine (NO-NIF) is a weak calcium channel blocker that is converted from nifedipine under light exposure. Recently, we reported that NO-NIF has potential as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishizawa, Keisuke, Izawa-Ishizawa, Yuki, Yamano, Noriko, Urushihara, Maki, Sakurada, Takumi, Imanishi, Masaki, Fujii, Shoko, Nuno, Asami, Miyamoto, Licht, Kihira, Yoshitaka, Ikeda, Yasumasa, Kagami, Shoji, Kobori, Hiroyuki, Tsuchiya, Koichiro, Tamaki, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904885/
https://www.ncbi.nlm.nih.gov/pubmed/24489716
http://dx.doi.org/10.1371/journal.pone.0086335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904885/
https://www.ncbi.nlm.nih.gov/pubmed/24489716
http://dx.doi.org/10.1371/journal.pone.0086335

Ejemplares similares